Envoy Medical (COCH) Cash from Investing Activities (2022 - 2025)
Envoy Medical's Cash from Investing Activities history spans 4 years, with the latest figure at -$172000.0 for Q4 2025.
- On a quarterly basis, Cash from Investing Activities fell 132.21% to -$172000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$179000.0, a 81.73% increase, with the full-year FY2025 number at -$179000.0, up 81.73% from a year prior.
- Cash from Investing Activities hit -$172000.0 in Q4 2025 for Envoy Medical, down from -$1000.0 in the prior quarter.
- Over the last five years, Cash from Investing Activities for COCH hit a ceiling of $534000.0 in Q4 2024 and a floor of -$790000.0 in Q2 2024.
- Historically, Cash from Investing Activities has averaged -$112750.0 across 4 years, with a median of -$50000.0 in 2022.
- The widest YoY moves for Cash from Investing Activities: up 2642.86% in 2024, down 7081.82% in 2024.
- Tracing COCH's Cash from Investing Activities over 4 years: stood at -$41000.0 in 2022, then soared by 48.78% to -$21000.0 in 2023, then skyrocketed by 2642.86% to $534000.0 in 2024, then tumbled by 132.21% to -$172000.0 in 2025.
- Business Quant data shows Cash from Investing Activities for COCH at -$172000.0 in Q4 2025, -$1000.0 in Q2 2025, and -$6000.0 in Q1 2025.